Aspen Pharmacare Holdings Limited
APNHF
$7.25
$0.8813.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.59% | 7.78% | 9.82% | 2.64% | 3.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.59% | 7.78% | 9.82% | 2.64% | 3.81% |
| Cost of Revenue | 1.68% | 0.93% | 16.03% | 8.44% | 9.23% |
| Gross Profit | 17.36% | 16.49% | 2.51% | -4.19% | -2.33% |
| SG&A Expenses | 12.32% | 11.48% | 7.40% | 0.37% | 1.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 52.57% | 51.43% | -503.98% | -477.54% | 70.48% |
| Total Operating Expenses | 7.04% | 6.25% | 10.49% | 3.26% | 8.75% |
| Operating Income | 16.36% | 15.50% | 7.64% | 0.60% | -15.52% |
| Income Before Tax | 14.49% | 13.64% | -13.44% | -19.10% | -17.08% |
| Income Tax Expenses | 40.26% | 39.22% | 2.33% | -4.36% | -10.48% |
| Earnings from Continuing Operations | 7.88% | 7.08% | -17.78% | -23.16% | -18.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.88% | 7.08% | -17.78% | -23.16% | -18.62% |
| EBIT | 16.36% | 15.50% | 7.64% | 0.60% | -15.52% |
| EBITDA | 16.09% | 15.22% | 8.32% | 1.23% | -12.13% |
| EPS Basic | 7.91% | 7.15% | -17.78% | -23.13% | -18.65% |
| Normalized Basic EPS | 14.55% | 13.75% | 8.20% | 1.16% | -17.07% |
| EPS Diluted | 7.91% | 7.15% | -17.78% | -23.13% | -18.65% |
| Normalized Diluted EPS | 14.55% | 13.75% | 8.20% | 1.16% | -17.07% |
| Average Basic Shares Outstanding | -0.05% | -0.05% | -0.02% | -0.02% | 0.03% |
| Average Diluted Shares Outstanding | -0.05% | -0.05% | -0.02% | -0.02% | 0.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.02% | 0.02% | -- | -- | 0.21% |